ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 917

$545K Total Retail Price of All Prescriptions

Rank: 92 out of 917

599 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 419 412 1 3
SIMVASTATIN 409 393 2 2
LISINOPRIL 295 283 3 1
WARFARIN SODIUM 244 240 4 10
HYDROCHLOROTHIAZIDE 226 211 5 9
FUROSEMIDE 221 206 6 7
HYDROCODONE-ACETAMINOPHEN 191 133 S3 7 6
OMEPRAZOLE 182 173 8 4
AMLODIPINE BESYLATE 159 151 9 5
METFORMIN HCL 156 137 10 8
LOSARTAN POTASSIUM 153 150 11 13
ATENOLOL 144 138 12 12
ATORVASTATIN CALCIUM 130 127 13 14
LOVASTATIN 127 124 14 19
GABAPENTIN 112 103 15 17
METOPROLOL SUCCINATE 112 106 15 18
CITALOPRAM HBR 110 94 17 15
DONEPEZIL HCL 99 99 18 32
TRAMADOL HCL 93 81 19 28
ZOLPIDEM TARTRATE 86 81 20 21
METOPROLOL TARTRATE 86 86 20 11
MIRTAZAPINE 86 84 20 39
NAMENDA 83 83 23 43
FLUTICASONE PROPIONATE 81 70 24 26
PREDNISONE 77 77 25 34
BENAZEPRIL HCL 75 66 26 80
KLOR-CON M20 74 65 27 121
TAMSULOSIN HCL 73 73 28 25
SERTRALINE HCL 69 65 29 24
PRAVASTATIN SODIUM 67 67 30 20
CRESTOR 66 54 31 30
TRAZODONE HCL 64 58 32 22
TRIAMTERENE-HCTZ 64 64 32 36
CARVEDILOL 62 62 34 33
AZITHROMYCIN 62 62 34 61
OXYCODONE HCL 62 31 S2 34 27
PANTOPRAZOLE SODIUM 61 55 37 44
TERAZOSIN HCL 61 61 37 108
POTASSIUM CHLORIDE 61 56 37 16
SYNTHROID 57 57 40 68
CLOPIDOGREL 54 54 41 50
ENALAPRIL MALEATE 52 52 42 79
QUETIAPINE FUMARATE 51 51 43 52
VENLAFAXINE HCL ER 51 43 43 78
FINASTERIDE 50 49 45 77
DIGOXIN 50 50 45 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.